Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Orphazyme A/S
  6. Company
    ORPHA   DK0060910917

ORPHAZYME A/S

(ORPHA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Orphazyme A/S
Orphazyme A/S, formerly Orphazyme ApS, is a Denmark-based company active within the biopharmaceutical industry. It develops new therapies for the treatment of a family of genetic disorders. The Company's main focus is on preclinical development of medicines for the treatment of lysosomal storage diseases (LSDs), a group of approximately 50 genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, and protein aggregation diseases. The Company’s candidate, arimoclomol, stimulates the production of the cells’ protein rescue system, the heat shock proteins, which helps the misfolded proteins to either get back to their functional shape or, if this cannot be achieved, remove them from the cells by means of the cells’ recycling system, the lysosomes, so they no longer form toxic aggregates. The Company collaborates with academic institutions in Europe and the United States.

Number of employees : 141 people.
Managers
Name Title Age Since
Christophe Bourdon Chief Executive Officer - 2021
Anders Fink Vadsholt Chief Financial Officer 51 2021
Thomas Kirkegaard Jensen, Dr. Chief Scientific Officer 43 2010
Claus Bornæs, Dr. Senior Manager-Research & Development - 2011
Thomas Blaettler, Dr. Chief Medical Officer 53 2016
Georges Gemayel, Dr. Chairman 60 2014
Martin N. Bonde, Dr. Independent Director 57 2010
Catherine Moukheibir Independent Director 60 2017
Carrolee Barlow, Dr. Independent Director 56 2020
Members of the board
Name Title Age Since
Georges Gemayel, Dr. Chairman 60 2014
Bo Jesper Hansen, Dr. Deputy Chairman 62 2017
Martin N. Bonde, Dr. Independent Director 57 2010
Catherine Moukheibir Independent Director 60 2017
Carrolee Barlow, Dr. Independent Director 56 2020
Stephanie S. Okey Director 60 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 34,952,241 34,450,821 98.6% 0 0.0% 98.6%
Shareholders
NameEquities%
Orpha Pooling BV 2,431,672 6.96%
Novo Holdings A/S (Investment Company) 2,027,879 5.80%
Sunstone Capital A/S 1,789,845 5.12%
Aescap Venture Management BV 1,758,105 5.03%
Danske Bank A/S (Investment Management) 1,717,536 4.91%
Consonance Capital Management LP 1,339,909 3.83%
Rémi Droller 905,525 2.59%
Handelsbanken Fonder AB 739,810 2.12%
SPSW Capital GmbH 586,000 1.68%
Fjärde AP-fonden 534,285 1.53%
Company contact information
Orphazyme A/S
Ole Maaløes Vej 3
Copenhagen, Capital Region 2200

Phone : +45.39.17.82.72
Web : http://www.orphazyme.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Orphazyme A/S
Sector Bio Therapeutic Drugs